Some real Redux data

Data published in the New England Journal of Medicine provide evidence from controlled clinical trials that Interneuron Pharmaceuticals Inc.'s Redux dexfenfluramine and other diet drugs may cause heart valve abnormalities, as anecdotal evidence had suggested.

The data come shortly after IPIC's announcement that it has proposed a $70 million settlement of litigation by patients who have taken Redux